Adverse Reactions of Iodixanol (270mg I/mL) in Coronary CT Angiography

张保翠,罗晶晶,王霄英,吴静云,张来运,陈卫东
DOI: https://doi.org/10.13609/j.cnki.1000-0313.2014.03.007
2014-01-01
Abstract:Objective:To report the adverse reactions related to iodinated contrast medium in patients undergoing coronary CT angiography using iodixanol(270mg I/mL).Methods:A total of 824consecutive patients' data undergoing coronary CTA were analyzed retrospectively.The adverse reactions related to contrast media within 1week were recorded,including acute and delayed adverse reactions,and renal impairment.Results:One patient was reported of acute moderate adverse reactions,with incidence of 0.12%(1/824).Nine patients were reported of delayed adverse reactions,with incidence 1.09%(9/824).Three patients were reported of contrast-induced nephropathy,with incidence of 2.61%(3/115).Conclusion:Iodixanol is safe for clinical application.
What problem does this paper attempt to address?